North Carolina Sen. Richard Burr is the top recipient of pharmaceutical industry lobbying contributions in Congress. By Stuart Silverstein FairWarning When the Republican-controlled Congress approved a landmark program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. Instead, […]
